Oil, gold to gain on Syria strikes; Russian retaliation in focus
LONDON (Reuters) – Gold and oil will extend their gains on Monday, albeit modestly, when markets open for the first time since Western powers launched a missile attack on Syria,…
by October Gallery
LONDON (Reuters) – Gold and oil will extend their gains on Monday, albeit modestly, when markets open for the first time since Western powers launched a missile attack on Syria,…
LONDON (Reuters) – Martin Sorrell’s sudden exit from WPP marks a shocking end to the career of a chief executive who through sheer force of personality made it the world’s…
LONDON (Reuters) – Martin Sorrell, who built WPP into the world’s biggest advertising agency through 33 years of dealmaking, quit on Saturday after an allegation of personal misconduct. FILE PHOTO:…
LONDON (Reuters) – Martin Sorrell quit as the head of WPP on Saturday, leaving the world’s biggest advertising agency 33 years after he founded it due to an investigation into…
BERLIN (Reuters) – German Interior Minister Horst Seehofer said on Saturday he would press for “reasonable results” in the next round of pay talks with more than two million public…
LONDON (Reuters) – After shaking up the music industry, Spotify (SPOT.N) is now prompting investors to question the value they get from investment banks underwriting new listings with its low-cost…
The international chemical weapons watchdog on Thursday confirmed Britain’s finding that a former Russian spy and his daughter were poisoned with a nerve agent, as Russia continued to deny suggestions…
BERLIN/MUNICH (Reuters) – Labor representatives at Volkswagen (VOWG_p.DE) are concerned by a sudden rush by the German carmaker’s board to approve sweeping changes on Thursday, sources said, while Handelsblatt reported…
BRUSSELS/SAN FRANCISCO (Reuters) – The European Union’s top antitrust regulator, Margrethe Vestager, has made it her mission to stem alleged anti-competitive abuses by big American tech companies, threatening as recently…
(Reuters) – Alex ion Pharmaceuticals has agreed to buy Sweden’s Wilson Therapeutics for 7.1 billion Swedish crowns ($855 million), boosting its line-up of rare disease drugs as a wave of…